IntroductionHigh-dose Vitamin C has shown significant anti-tumor effects in various cancers, including hematological malignancies.
However, its therapeutic efficacy against acute lymphoblastic leukemia (ALL) remains underexplored.MethodsALL cell lines and normal bone marrow mononuclear cells were treated with Vitamin C to assess cell viability, apoptosis, proliferation, and cell cycle progression.
Colony formation assays evaluated long-term growth.
Additionally, transgenic mouse models were employed to evaluate the
